MENU ABOUT US MAKE A DONATION
The Epoch Times
Login
SEARCH
CLOSE
Help Center subscribe newsletter Newsstands Epoch Shop Gift
  • TOP NEWS
  • SPECIAL SERIES
  • SPECIAL COVERAGE
  • LATEST ARTICLES
  • US
    • US News
    • US Features
    • Politics
    • Crime and Incidents
    • New York
    • San Francisco
    • Los Angeles
  • Opinion
    • Thinking About China
    • Viewpoints
    • Unbridled Evil: The Corrupt Reign of Jiang Zemin in China
    • The Reader’s Turn
    • America Essay Contest
  • China
    • US-China Relations
    • Chinese Regime
    • Business & Economy
    • Chinese Culture
    • China Human Rights
    • Social Issues
    • Organ Harvesting in China
  • World
    • Africa
    • Americas
    • Asia & Pacific
    • Canada
    • Europe
    • UK
    • Australia
    • International
    • Middle East
  • Business & Markets
    • Companies
    • Economy
    • Markets
    • Real Estate
  • ARTS & CULTURE
    • Fine Arts & Craftsmanship
    • Performing Arts
    • Books
    • Traditional Culture
    • Shen Yun Special Coverage
    • Film & TV
  • Science
    • News
    • Space
    • Environment
  • Tech
    • Tech News
    • Tech Products & Reviews
    • Social Media
  • Sports
  • Video
    • American Thought Leaders
    • China Insider
    • Crossroads
  • Bright
    • Lifestyle
    • Inspired
    • Family & Education
    • Personal Finance
    • American Essence
  • Entertainment
    • Film & TV
    • Entertainment News
  • Health
    • Experts
    • Health Conditions
    • Wellness
  • News
  • Sponsored Content
SEARCH
  • EpochTV
  • US
  • Politics
  • Opinion
  • World
  • China
  • Hong Kong
  • Health
  • Business & Markets
  • Bright
  • Arts
  • Premium
  • Games
  • Sports
  • Livestream
  • More

antibody

  • GSK’s Blood Cancer Drug Fails Main Goal of Trial, Shares Fall
    GSK’s Blood Cancer Drug Fails Main Goal of Trial, Shares Fall
    GSK's blood cancer drug Blenrep failed the main goal of a late-stage study designed to show it was better than an existing treatment on the market, the company said on ...
    November 7, 2022BY Reuters
  • Scientists Find Antibodies That Neutralize All COVID Strains
    Scientists Find Antibodies That Neutralize All COVID Strains
    Previous monoclonal antibody treatments against COVID-19 have had mixed results against variants. However, new research uncovered two antibodies ...
    October 13, 2022BY Joseph Mercola
  • New Science Shows Vaccines Help Omicron Spread: Peer-Reviewed Study
    New Science Shows Vaccines Help Omicron Spread: Peer-Reviewed Study
    A team of 19 scientists from the United Kingdom have published new research that helps explain why countries ...
    August 5, 2022BY Jennifer Margulis and Joe Wang
  • IgA Antibodies Appear to Protect Unvaccinated Against COVID-19: Study
    IgA Antibodies Appear to Protect Unvaccinated Against COVID-19: Study
    Findings from a study in Sweden provide one possible explanation for why some health care workers who were ...
    March 29, 2022BY Mimi Nguyen Ly
  • Lab Tests: Eli Lilly, Regeneron Antibody Therapies Lose out Against Omicron
    Lab Tests: Eli Lilly, Regeneron Antibody Therapies Lose out Against Omicron
    FRANKFURT, GERMANY—German researchers have found that COVID-19 therapies developed by Eli Lilly and Regeneron lose most of their ...
    December 16, 2021BY Reuters
  • Professor of Medicine Says Data Does Not Show Occurrence of Antibody-Dependant Enhancement
    Professor of Medicine Says Data Does Not Show Occurrence of Antibody-Dependant Enhancement
    News Analysis Real-world data is not showing antibody-dependent enhancement of disease occurring in COVID-19 vaccinated populations, Dr. Jay ...
    August 27, 2021BY Meiling Lee
  • UK-wide Antibody Testing Programme to Be Launched for COVID-19-Positive People
    UK-wide Antibody Testing Programme to Be Launched for COVID-19-Positive People
    A UK-wide antibody testing programme is to be launched for people who have contracted coronavirus, the government has ...
    August 22, 2021BY PA Media
  • NTD Evening News Full Broadcast (Aug. 20)
    NTD Evening News Full Broadcast (Aug. 20)
    Evacuation efforts have flown 13,000 Americans and Afghans out of Afghanistan since last week, people trying to evacuate must escape ...
    August 20, 2021BY NTD Television
  • BioNTech COVID-19 Vaccine Produces 10 Times More Antibodies Than China’s Sinovac: Study
    BioNTech COVID-19 Vaccine Produces 10 Times More Antibodies Than China’s Sinovac: Study
    A new study by researchers in Hong Kong has found that recipients of BioNTech's Comirnaty COVID-19 vaccine generate 10 ...
    July 18, 2021BY Alex Wu
  • Research Suggests Mild COVID-19 Illness Leaves Behind Lasting Antibody Protection
    Research Suggests Mild COVID-19 Illness Leaves Behind Lasting Antibody Protection
    People who had mild COVID-19 have long-lasting antibody protection, according to a study by researchers from Washington University ...
    June 1, 2021BY Meiling Lee
  • Elderly Show Similar Antibody Response to 1st Dose of AstraZeneca, Pfizer COVID-19 Shots: UK Study
    Elderly Show Similar Antibody Response to 1st Dose of AstraZeneca, Pfizer COVID-19 Shots: UK Study
    LONDON—The first study to directly compare immune reactions between Pfizer's and AstraZeneca's COVID-19 vaccines found strong and broadly ...
    April 14, 2021BY Reuters
  • Get Used to Annual Revaccination Against COVID-19, Boris Johnson Says
    Get Used to Annual Revaccination Against COVID-19, Boris Johnson Says
    People will have to get used to the idea of annual revaccination against the CCP virus as new ...
    February 10, 2021BY Alexander Zhang
  • UK Identifies 2 More COVID-19 Variants With Vaccine-Resistant Mutation
    UK Identifies 2 More COVID-19 Variants With Vaccine-Resistant Mutation
    British health authorities have identified two more COVID-19 variants with a mutation that makes them resistant to vaccines. ...
    February 10, 2021BY Alexander Zhang
  • Regeneron: Antibody Cocktail 100 Percent Effective Against Symptomatic COVID-19 Infections
    Regeneron: Antibody Cocktail 100 Percent Effective Against Symptomatic COVID-19 Infections
    Regeneron Pharmaceuticals on Tuesday announced that a phase 3 trial still in progress of an antibody cocktail has ...
    January 26, 2021BY Zachary Stieber
  • FDA Gives Eli Lilly’s Experimental COVID-19 Antibody Drug Emergency Clearance
    FDA Gives Eli Lilly’s Experimental COVID-19 Antibody Drug Emergency Clearance
    U.S. drug regulators granted Eli Lilly’s COVID-19 antibody drug an emergency-use authorization on Monday, widening access to a ...
    November 10, 2020BY Isabel van Brugen
  • More Test Positive in Expanded New York Antibody Testing
    More Test Positive in Expanded New York Antibody Testing
    More New Yorkers tested positive for antibodies to the CCP virus in expanded testing done at grocery stores. ...
    April 27, 2020BY Zachary Stieber
  • Most Antibody Tests Not Validated, Unclear Whether Recovered People Are Immune to Virus: Fauci
    Most Antibody Tests Not Validated, Unclear Whether Recovered People Are Immune to Virus: Fauci
    Most antibody tests circulating among the public aren't validated, Dr. Anthony Fauci said, while also saying it hasn't ...
    April 20, 2020BY Zachary Stieber
TOP NEWS
  • RNC Urges Republicans to Expose Democrats’ ‘Extreme’ Abortion Stance
    NEW By Caden Pearson
    RNC Urges Republicans to Expose Democrats’ ‘Extreme’ Abortion Stance
  • Beijing Promotes Rice Bran as Food Amid Famine Fears
    2hr By Tiffany Meier
    Beijing Promotes Rice Bran as Food Amid Famine Fears
  • Biden Admin Plans to End COVID-19 Emergency Declarations on May 11
    3hr By Mimi Nguyen Ly
    Biden Admin Plans to End COVID-19 Emergency Declarations on May 11
  • California’s Crime Wave: EpochTV Documentary on Alarming Trend
    3hr By Sophie Li
    California’s Crime Wave: EpochTV Documentary on Alarming Trend
  • Brooklyn District Attorney Investigates Allegations of Democrat Voter Fraud
    3hr By Jackson Elliott
    Brooklyn District Attorney Investigates Allegations of Democrat Voter Fraud
  • Democrats Vow to Audit Durham Probe Based on New York Times’ Anonymous Sources
    4hr By Juliette Fairley
    Democrats Vow to Audit Durham Probe Based on New York Times’ Anonymous Sources
  • San Francisco, Los Angeles Top List of Cities Homebuyers Looked to Leave in 2022: Report
    4hr By Jill McLaughlin
    San Francisco, Los Angeles Top List of Cities Homebuyers Looked to Leave in 2022: Report
  • Jury Acquits Pro-Life Activist Whose Home Was Raided by FBI
    4hr By Samantha Flom
    Jury Acquits Pro-Life Activist Whose Home Was Raided by FBI
  • California Bill Would Seal Name, Gender Change Records of Minors
    4hr By Brad Jones
    California Bill Would Seal Name, Gender Change Records of Minors
  • Witnesses on ‘Biden’s Border Crisis’ Set for Judiciary Committee
    4hr By Janice Hisle
    Witnesses on ‘Biden’s Border Crisis’ Set for Judiciary Committee
The Epoch Times
Help Center subscribe newsletter Newsstands Epoch Shop Gift
  • TOP NEWS
  • SPECIAL SERIES
  • SPECIAL COVERAGE
  • LATEST ARTICLES
You deserve to hear the truth.
  • Contact Us
  • Media Statements
  • About Us
  • RSS Feeds
  • Terms of Services
  • Privacy Policy
  • Copyright Policy
  • Data Disclaimer
  • Digital Newspaper
  • Our Story
  • Subscribe
  • Careers
36 COUNTRIES, 22 LANGUAGES
  • Bulgarian
  • English
  • Chinese
  • Spanish
  • Japanese
  • Korean
  • Indonesian
  • French
  • German
  • Italian
  • Portuguese
  • Swedish
  • Dutch
  • Russian
  • Ukrainian
  • Romanian
  • Czech
  • Slovak
  • Polish
  • Turkish
  • Persian
  • Vietnamese
DOWNLOAD OUR APP
iOS Android
  • US
    • US News
    • US Features
    • Politics
    • Crime and Incidents
    • New York
    • San Francisco
    • Los Angeles
  • Opinion
    • Thinking About China
    • Viewpoints
    • Unbridled Evil: The Corrupt Reign of Jiang Zemin in China
    • The Reader’s Turn
    • America Essay Contest
  • China
    • US-China Relations
    • Chinese Regime
    • Business & Economy
    • Chinese Culture
    • China Human Rights
    • Social Issues
    • Organ Harvesting in China
  • World
    • Africa
    • Americas
    • Asia & Pacific
    • Canada
    • Europe
    • UK
    • Australia
    • International
    • Middle East
  • Business & Markets
    • Companies
    • Economy
    • Markets
    • Real Estate
  • ARTS & CULTURE
    • Fine Arts & Craftsmanship
    • Performing Arts
    • Books
    • Traditional Culture
    • Shen Yun Special Coverage
    • Film & TV
  • Science
    • News
    • Space
    • Environment
  • Tech
    • Tech News
    • Tech Products & Reviews
    • Social Media
  • Sports
  • Video
    • American Thought Leaders
    • China Insider
    • Crossroads
  • Bright
    • Lifestyle
    • Inspired
    • Family & Education
    • Personal Finance
    • American Essence
  • Entertainment
    • Film & TV
    • Entertainment News
  • Health
    • Experts
    • Health Conditions
    • Wellness
  • News
  • Sponsored Content
Copyright © 2000 - 2023 The Epoch Times Association Inc. All Rights Reserved.
Back Top
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Use. More informationI accept×